Article info

Download PDFPDF
New details emerge about the implementation of the Falsified Medicines Directive's safety features and verification requirements
  1. Correspondence to Richard Price, Department of Policy and Advocacy, European Association of Hospital Pharmacy, 3 Rue Abbe Cuypers, Brussels 1040, Belgium; richard.price{at}eahp.eu
View Full Text

Citation

Price R
New details emerge about the implementation of the Falsified Medicines Directive's safety features and verification requirements

Publication history

  • First published June 25, 2015.
Online issue publication 
June 25, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.